TWINBEECH CAPITAL LP

Position in GILD — Gilead Sciences, Inc.

CIK 1769646 PURCHASE, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$534,544

-$1,058,375 QoQ

Shares Held

4,231

-67.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#1,338

of 2,265 holders

Holding Since

Dec 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TWINBEECH CAPITAL LP holds $3,064,076 across 3 Drug Manufacturers - General names. GILD ranks #3 (17.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,454	$1,743,971
2	PFE	Pfizer Inc	32,623	$785,561
3	GILD	Gilead Sciences, Inc. This page	4,231	$534,544

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$534,544	4,231	-67.4%	Shares	Sole	2026-08-14
2025-12-31	$1,592,919	12,978	-46.7%	Shares	Sole	2026-02-17
2025-09-30	$2,701,518	24,338	-86.4%	Shares	Sole	2025-11-14
2023-12-31	$14,507,108	179,078	-36.2%	Shares	Sole	2024-02-14
2023-06-30	$21,623,452	280,569	+8921.5%	Shares	Sole	2023-08-14
2021-12-31	$225,817	3,110	-83.2%	Shares	Sole	2022-02-14
2020-12-31	$1,078,742	18,516	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.